# Stem Cell Therapy for Type 1 Diabetes Mellitus

> **NCT01143168** · PHASE1 · UNKNOWN · sponsor: **Cellonis Biotechnology Co. Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** autologous bone marrow mononuclear cells and umbilical cord mesenchymal stem cells

## Key facts

- **NCT ID:** NCT01143168
- **Lead sponsor:** Cellonis Biotechnology Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-08
- **Primary completion:** 2011-08
- **Final completion:** 2011-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01143168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01143168, "Stem Cell Therapy for Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01143168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*